Mental health disorders are a major public health problem, with an estimated one in four people in the United States experiencing a mental disorder in any given year.1 Treatment options for mental health disorders are limited, and often involve a combination of psychotherapy and medication. Recently, a new medication, lurasidone, has been developed to treat a variety of mental health disorders, including bipolar disorder, schizophrenia, and major depressive disorder. This article will discuss the potential benefits of lurasidone, as well as the potential risks associated with its use.
Lurasidone is an atypical antipsychotic medication that was approved by the US Food and Drug Administration in 2009. It is a serotonin-dopamine antagonist, meaning that it works by blocking the action of serotonin and dopamine, two neurotransmitters that are involved in the regulation of mood and behavior.2 Lurasidone is thought to be effective in treating a variety of mental health disorders, including bipolar disorder, schizophrenia, and major depressive disorder.
The primary benefit of lurasidone is its ability to reduce symptoms of mental health disorders. Studies have shown that lurasidone is effective in reducing the symptoms of bipolar disorder, schizophrenia, and major depressive disorder.3,4,5 In addition, lurasidone has been shown to be effective in reducing anxiety symptoms in people with bipolar disorder.6 In addition to reducing symptoms, lurasidone has also been shown to improve quality of life in people with mental health disorders. Studies have found that lurasidone can improve overall functioning and reduce the need for hospitalization in people with bipolar disorder and schizophrenia.7,8 Finally, lurasidone may be beneficial in reducing the risk of suicide in people with mental health disorders. Studies have found that lurasidone can reduce the risk of suicide attempts in people with bipolar disorder and schizophrenia.9,10
As with any medication, there are potential risks associated with lurasidone. The most common side effects of lurasidone include nausea, weight gain, fatigue, and dry mouth.11 Other potential side effects include increased blood sugar levels, increased risk of stroke, and increased risk of death in elderly patients with dementia.12 In addition, lurasidone can interact with other medications, including certain antidepressants and anticonvulsants.13 Therefore, it is important to discuss any potential medication interactions with your doctor before starting lurasidone.
Lurasidone is a new medication that has been developed to treat a variety of mental health disorders, including bipolar disorder, schizophrenia, and major depressive disorder. It is thought to be effective in reducing symptoms and improving quality of life in people with mental health disorders. However, there are potential risks associated with lurasidone, including side effects and interactions with other medications. Therefore, it is important to discuss the potential risks and benefits of lurasidone with your doctor before starting treatment.
1.
According to JAMA, 5 alpha-reductase inhibitors are not significantly linked to prostate cancer mortality.
2.
Nanoparticle vaccine prevents multiple cancers and stops metastasis in mice
3.
Childhood brain tumors develop early in highly specialized nerve cells, research reveals
4.
Marstacimab Gets FDA Nod for Hemophilia A or B Without Inhibitors
5.
For patients with clear cell renal cell carcinoma, a new PET agent allows for same-day imaging.
1.
The Essential Roadmap for Nutritional Excellence in Head and Neck Cancer Care
2.
Don't Ignore Your Vision Loss: What You Need to Know About Amaurosis Fugax
3.
Cancer Rates on the Rise: What Can We Do to Stop It?
4.
The Importance of Understanding Carboxyhemoglobin Levels in the Body: A Comprehensive Guide
5.
Theranostics and Radioligand Therapy: Precision Cancer Care with Targeted Radionuclides
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World
2.
Managing CNS diseases at the point of diagnosis in ALK + NSCLC
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
4.
An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.
5.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation